查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1969239

血液製品市场：按交付形式、成分、加工自动化程度、製备方法、应用和最终用户划分－2026-2032年全球预测

Blood Preparation Market by Offerings, Component, Processing Automation, Preparation Method, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2025年血液製品市场价值为480.9亿美元，预计到2026年将成长至508.1亿美元，复合年增长率为5.93%，到2032年将达到719.8亿美元。

主要市场统计数据
基准年 2025 480.9亿美元
预计年份：2026年 508.1亿美元
预测年份 2032 719.8亿美元
复合年增长率 (%) 5.93%

全面介绍目前血液製品生态系统如何影响营运策略，重点关注技术驱动因素、相关人员的优先事项和采购考量。

随着越来越多的机构要求更安全、更有效率、更可追溯的生物製药流通，血液製品生态系统在技术和运作方面正迅速发展。采集和储存设备的进步，以及用于设施管理和温度监控的软体层的不断扩展，正在重新定义捐血和处理到储存和分发的整个工作流程。从血库和医院输血科到门诊手术中心和研究机构，相关人员都在重新评估采购优先事项，以强调韧性、自动化和整合品管。

对技术、营运和采购的变革性转变进行全面展望，重新定义血液製品产业的安全、自动化和供应商合作。

血液製品领域正沿着多个相互融合的方向发展，这些方向正在改变供应链和临床实践。首先，自动化不再局限于提高单一仪器的效率，而是发展为协调的工作流程，整合自动化的成分提取、离心和温度感测储存系统，从而减少人工操作和操作差异。其次，诸如白血球去除、辐照和病原体灭活等安全技术正被更早地应用于处理流程中，以降低下游风险并支援更广泛的应用情境。第三，软体驱动的流程管治日趋成熟，温度监控系统和血液设施管理系统提供了审核和合规性支持，而这些功能传统上依赖人工记录。

对累积关税措施如何重塑整个血液製品价值链的采购趋势、供应商策略和业务连续性进行清晰分析。

近期推出的关税措施显着增加了整个血液製品价值链采购和供应的韧性难度。进口组件、资本设备和某些耗材的累积关税提高了依赖跨境供应商的机构的总拥有成本，促使许多机构重新评估其供应商集中度和前置作业时间。因此，采购团队正优先考虑双重采购策略，并与本地製造商密切合作，以降低贸易政策波动带来的风险。

将采购和创新重点与产品供应、加工方法、临床应用、自动化程度、组件和最终用户需求进行匹配的关键细分洞察。

市场区隔驱动着产品开发蓝图和采购选择，因为最终用户需要清楚了解产品如何满足其临床和营运需求。根据产品类型，市场分为「一次性耗材」、「设备」和「软体」。一次性耗材包括血浆分离试剂盒、血袋系统、白血球去除过滤器、输血套装、输液管和针头等，这些决定了血站和医院每次操作的成本和利润率。设备包括采血装置、辐照装置、病原体移除系统、处理装置和储存装置。采血装置进一步分为血浆分离装置和血液混合器，而处理装置包括自动成分分离器和离心机。储存装置包括血库冷藏库、低温冷冻库、血浆冷冻库、血小板培养箱和振盪器。软体涵盖血液设施解决方案和温度监控平台，这些平台可实现库存管理和监管追溯。

这份综合情报报告分析了细微的区域差异，解释了美洲、欧洲、中东和非洲以及亚太地区的趋势如何影响采用率、供应弹性和监管合规性。

区域趋势对供应链、法规要求以及新型血液製品技术的应用进度有显着影响。美洲地区拥有大规模的现有血液服务基础设施、先进的医院系统，并且日益重视自动化和安全技术。在这种环境下，报销机制、与现有供应商的关係以及温控产品长途配送的物流实际情况都会影响采购决策。

可用于公司层面的竞争讯息，了解供应商策略、服务模式和伙伴关係方式如何塑造整个血液製品生态系统的竞争优势。

血液製品产业的竞争动态更取决于其在生态系统中的定位，而非单一产品的优越性。主要企业透过整合一次性产品、资本设备和软体能力的综合产品组合来脱颖而出，提供端到端的价值提案，既满足采购对可预测生命週期成本的需求，又能最大限度地减少与供应商的接触。主要供应商采取的策略性措施包括：与临床网路建立伙伴关係以检验新的处理技术；投资建置区域服务中心以缩短维护前置作业时间；以及提供培训和认证专案以降低采用先进设备的门槛。

为血液製品产业的供应商、医疗保健系统和采购经理提供切实可行的优先建议，以增强韧性、安全性和技术整合。

产业领导者应优先采取一系列策略行动，直接提升供应的韧性、安全性和完整性。首先，他们应采用模组化筹资策略，平衡血液采集和储存设施的资本投资与耗材和维护的长期合同，以稳定总体拥有成本，并降低关税波动带来的价格衝击。其次，他们应加快血液设施管理和温度监控软体的集成，建立透明且审核的工作流程，以减少人为错误并支援合规性。

一个稳健的多方法研究框架，结合了对关键相关人员的访谈、对二手技术和监管资讯的整合，以及使用三角测量法进行主题检验，以支持策略见解。

本执行摘要的分析结合了多种研究方法，旨在得出可操作的、基于证据的见解。对二手资讯的整合利用了同行评审文献、监管指南、技术标准和製造商规范，从而建立了技术、流程和合规要求的全面整体情况。一手研究则透过对血库经理、医院输血科经理、采购负责人、临床病理学家和医疗设备技术人员的结构化访谈进行，以确定实际应用中的限制和推动因素。

血液製品相关人员的一项关键要求是，要果断地整合策略重点和营运协调，从而将安全性、韧性和完整性结合起来。

研究结果一致表明，医疗服务提供者和供应商应从基于交易的关係转向整合价值的伙伴关係，将弹性采购、自动化和数据驱动的品质系统相结合。服务提供者应将流程自动化、病原体减少和软体管治的投资视为策略基础，而不仅仅是资本计划，以实现临床一致性和供应弹性。能够提供模组化、服务丰富且互通性解决方案的供应商，最能满足从门诊手术中心到大型医院网路等不同终端用户的细微需求。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 血液製品市场：依供应方式划分

  • 一次性用品和消耗品
    • 血浆分离试剂盒
    • 血袋系统
    • 白血球去除过滤器
    • 传输组
    • 管子和针头
  • 装置
    • 采血装置
      • 血液分离装置
      • 血液采集混合器
    • 照射装置
    • 病原体减少系统
    • 处理单元
      • 自动组件提取装置
      • 离心机
    • 保藏设备
      • 血库用冷藏库
      • 超低温冷冻库
      • 等离子冷冻库
      • 血小板培养箱及搅拌装置
  • 软体
    • 血液设施
    • 温度控制

第九章 血液製品市场：依成分划分

  • 电浆
  • 血小板
  • 红血球
  • 全血

第十章：血液製品市场加工自动化

  • 全自动
  • 手动的
  • 半自动

第十一章 依製备方法分類的血液製品市场

  • 血液分离术
  • 提取工作流程
  • 冷冻/低温保存
  • 辐射照射
  • 白血球去除
  • 病原体灭活
  • 洗涤和容量调节
  • 全血处理

第十二章 血液製品市场：依应用领域划分

  • 血浆衍生疗法
    • 自体免疫疾病与神经系统疾病
    • 肝病与重症监护
    • 原发性免疫力缺乏
  • 研究与生物製造
  • 输血支持
    • 贫血管理
    • 循环系统/移植
    • 血液疾病
    • 妇产科
    • 肿瘤治疗

第十三章 血液製品市场：依最终用户划分

  • 门诊手术中心
  • 血库
  • 诊所
  • 医院

第十四章 血液製品市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 血液製品市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 血液製品市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章：美国血液製品市场

第十八章：中国血液製品市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Abbott Laboratories
  • AdvaCare Pharma
  • AstraZeneca PLC
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Bayer AG
  • Becton, Dickinson, and Company
  • Cardinal Health
  • CSL Limited
  • Daiichi Sankyo
  • Delcon SRL
  • Exelint International, Co.
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Greiner Bio-One International GmbH
  • Grifols, SA
  • GVS SpA
  • Immucor, Inc.
  • Kedrion Holding SpA
  • Labotronics Scientific LTD.
  • Labtron Equipment Ltd
  • LFB SA
  • Macopharma SAS
  • Medline Industries, Inc.
  • Medtronic PLC
  • Mitra Industries Private Limited
  • Nipro Corporation
  • Octapharma AG
  • Ortho Clinical Diagnostics Inc.
  • Pfizer Inc.
  • QIAGEN NV
  • Sanquin
  • SARSTEDT AG & Co. KG
  • Shanghai Kohope Medical Devices Co., Ltd.
  • Terumo Corporation
Product Code: MRR-535C62918769

The Blood Preparation Market was valued at USD 48.09 billion in 2025 and is projected to grow to USD 50.81 billion in 2026, with a CAGR of 5.93%, reaching USD 71.98 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 48.09 billion
Estimated Year [2026] USD 50.81 billion
Forecast Year [2032] USD 71.98 billion
CAGR (%) 5.93%

A comprehensive orientation to the current blood preparation ecosystem highlighting technological enablers, stakeholder priorities, and procurement considerations shaping operational strategy

The blood preparation ecosystem is undergoing a period of rapid technological and operational refinement as institutions seek safer, more efficient, and more traceable flows of biological products. Advances in collection and storage hardware, combined with a growing software layer for establishment management and temperature monitoring, are redefining workflows across donation, processing, storage, and distribution. Stakeholders from blood banks and hospital transfusion services to ambulatory surgical centers and research organizations are recalibrating procurement priorities to emphasize resiliency, automation, and integrated quality controls.

Against this backdrop, procurement decision-makers must balance capital investments in collection devices, pathogen reduction systems, and storage infrastructure with recurring consumable needs such as apheresis kits, tubing, and filters. At the same time, clinical teams are emphasizing component integrity for plasma-derived therapies, transfusion support in oncology and cardiology, and specialized needs for immune and hepatic care. The introductory framing here establishes the operational tensions that follow through the analysis: securing supply continuity, minimizing contamination risk, and enabling seamless traceability through both hardware and software interventions.

An integrated view of transformative technological, operational, and procurement shifts that are redefining safety, automation, and supplier engagement across blood preparation

The landscape of blood preparation is shifting along several convergent vectors that are transforming both supply chains and clinical practice. First, automation is moving beyond single-instrument gains toward orchestrated workflows that integrate automated component extraction, centrifugation, and temperature-aware storage systems, thereby reducing manual handling and variability. Second, safety technologies such as leukoreduction, irradiation, and pathogen inactivation are becoming embedded earlier in processing pathways to reduce downstream risk and support broader clinical use cases. Third, software-enabled process governance is maturing, with temperature monitoring and blood establishment systems providing auditability and compliance support that used to rely on manual recordkeeping.

These shifts are complemented by evolving end-user expectations; hospitals and clinics are increasingly demanding modular systems that can scale with changing case mixes and regulatory requirements. Research and biomanufacturing applications are driving adaptations in processing and storage capabilities to support plasma-derived therapies and novel biologic workflows. Finally, the interplay between disposables and capital equipment is changing procurement models, encouraging suppliers to present lifecycle propositions rather than standalone product sales. Together, these transformative shifts necessitate that clinical, operational, and purchasing leaders rethink supplier relationships, maintenance models, and integration strategies to capture the full value of technological advances.

A clear analysis of how cumulative tariff measures have reshaped procurement dynamics, supplier strategies, and operational resilience across the blood preparation value chain

Recent tariff actions have introduced a material layer of complexity into procurement and supply resilience across the blood preparation value chain. Cumulative tariff measures on imported components, capital equipment, and certain consumables have increased the total cost of ownership for institutions reliant on cross-border suppliers, prompting many organizations to reassess supplier concentration and lead times. As a result, procurement teams are prioritizing dual-sourcing strategies and closer collaboration with regional manufacturers to mitigate exposure to trade policy volatility.

Operationally, tariffs have affected decisions around capital replacement cycles and servicing contracts for items such as apheresis machines, pathogen reduction systems, and temperature-sensitive storage equipment. Institutions that had planned synchronized upgrades are reconsidering schedules to avoid short-term price escalations while continuing to manage compliance and safety imperatives. On the supplier side, manufacturers are responding with localized manufacturing investments, regional distribution hubs, and revised commercial models that emphasize bundled service agreements to offset tariff-driven margins. In parallel, regulatory and customs processing requirements associated with tariff regimes are demanding greater documentation and logistics lead time, which influences blood bank inventory strategies and the timing of elective procedures that depend on reliable transfusion support.

Essential segmentation insights that map offerings, processing methods, clinical applications, automation levels, components, and end-user demands to procurement and innovation priorities

Segmentation drives both product development roadmaps and procurement choices because end users require clarity on how offerings map to clinical and operational needs. Based on offerings, the market encompasses Disposables & Consumables, Equipment, and Software. Disposables & Consumables include items such as apheresis kits, blood bag systems, leukocyte reduction filters, transfer sets, and tubing and needles that determine per-procedure cost and margin for blood centers and hospitals. Equipment comprises collection devices, irradiators, pathogen reduction systems, processing equipment, and storage equipment; collection devices further break down into apheresis machines and blood collection mixers, processing equipment includes automated component extractors and centrifuges, and storage equipment captures blood bank refrigerators, cryogenic freezers, plasma freezers, and platelet incubators and agitators. Software covers blood establishment solutions and temperature monitoring platforms that enable inventory control and regulatory traceability.

Based on component, segmentation differentiates plasma, platelets, red blood cells, and whole blood, each with distinct processing, storage, and clinical utilization profiles. Based on processing automation, offerings span fully automated systems, manual workflows, and semi-automated solutions, which influence staffing models and throughput. Based on preparation method, the range includes apheresis processing, extraction workflows, freezing and cryopreservation, irradiation, leukoreduction, pathogen inactivation, washing and volume adjustment, and whole blood processing, each requiring specific consumables and equipment footprints. Based on application, the market addresses plasma-derived therapies, research and biomanufacturing, and transfusion support; plasma-derived therapies further subdivide into autoimmune and neurologic disorders, liver disease and critical care, and primary immunodeficiency, while transfusion support addresses anemia management, cardiovascular and transplant care, hematological disorders, obstetrics and gynecology, and oncology treatments. Finally, based on end user, demand channels include ambulatory surgical centers, blood banks, clinics, and hospitals, with each end user imposing different scale and compliance requirements that affect product selection and service needs.

A nuanced regional intelligence synthesis describing how Americas, Europe Middle East Africa, and Asia-Pacific dynamics influence adoption, supply resilience, and regulatory compliance

Regional dynamics exert substantial influence on supply chains, regulatory expectations, and adoption timelines for new blood preparation technologies. The Americas context features a mix of large established blood service infrastructures, advanced hospital systems, and an increasing focus on automation and safety technologies. In this environment, procurement decisions are influenced by reimbursement frameworks, established supplier relationships, and the logistical realities of long-distance distribution for temperature-sensitive products.

Europe, the Middle East & Africa presents a heterogeneous tableau where high-regulation markets drive early adoption of compliance-oriented software and pathogen reduction technologies, while emerging markets in the region prioritize scalable, cost-effective disposables and resilient storage solutions. Adoption patterns in this region are mediated by national blood service models and regional trade dynamics. The Asia-Pacific region is characterized by rapid capacity expansion in both hospital services and plasma collection infrastructure, a growing appetite for localized manufacturing to reduce import dependency, and increasing investment in automation and digital quality systems. Across all regions, the interplay between local regulatory frameworks, tariff influences, and healthcare delivery models shapes how quickly new equipment and processes are validated and scaled.

Actionable corporate-level intelligence on how supplier strategies, service models, and partnership approaches are shaping competitive advantage across the blood preparation ecosystem

Competitive dynamics in the blood preparation space are defined less by single-product dominance and more by ecosystem positioning. Leading players differentiate through comprehensive portfolios that combine disposables, capital equipment, and software capabilities, enabling end-to-end value propositions that address procurement preference for fewer vendor interfaces and predictable lifecycle costs. Strategic behaviors observed among major suppliers include forming partnerships with clinical networks to validate new processing technologies, investing in regional service footprints to shorten maintenance lead times, and offering training and accreditation programs that lower implementation friction for sophisticated equipment.

Smaller specialized suppliers are carving sustainable niches by focusing on high-margin consumables, modular add-ons for pathogen reduction, and software modules that integrate with legacy blood establishment systems. Contract manufacturing organizations and regional device assemblers have been expanding capabilities to serve localized demand, particularly where tariff pressures incentivize domestic sourcing. Across the competitive spectrum, successful companies are aligning commercial models to emphasize bundled service agreements, data-enabled support offerings, and interoperability that eases integration with existing blood center workflows.

Practical and prioritized recommendations for suppliers, health systems, and procurement leaders to strengthen resilience, safety, and technology integration in blood preparation

Industry leaders should prioritize a portfolio of strategic actions that directly address supply resilience, safety, and integration. First, adopt a modular procurement strategy that balances capital investment in collection and storage equipment with long-term agreements for disposables and maintenance to stabilize total cost of ownership and reduce exposure to tariff-driven price shocks. Second, accelerate integration of software for blood establishment and temperature monitoring to create transparent, auditable workflows that reduce manual error and support regulatory compliance.

Third, diversify supplier relationships by qualifying regional manufacturers and contract assemblers to shorten lead times and create buffer capacity for critical consumables. Fourth, invest in phased automation that aligns with staffing realities; prioritize semi-automated interventions that deliver immediate reductions in handling risk while planning for fully automated workflows where throughput and budget permit. Fifth, create clinical-laboratory partnerships to validate pathogen reduction and leukoreduction protocols in real-world settings, generating internal evidence that supports broader adoption and payer conversations. Finally, engage proactively with policymakers and customs authorities to streamline import documentation and advocate for tariff treatment that recognizes the clinical imperative of uninterrupted blood supply.

A robust, multi-method research framework combining primary stakeholder interviews, secondary technical and regulatory synthesis, and triangulated thematic validation to underpin strategic insights

The analysis underpinning this executive summary combines a multi-method research approach designed to produce actionable, evidence-based insights. Secondary source synthesis drew on peer-reviewed literature, regulatory guidance, technical standards, and manufacturer technical specifications to build a comprehensive picture of technologies, processes, and compliance requirements. Primary research was conducted through structured interviews with blood bank directors, hospital transfusion leads, procurement professionals, clinical pathologists, and device engineers to surface real-world constraints and adoption drivers.

Data triangulation integrated qualitative interview findings with product feature mappings, supply chain case studies, and regional regulatory reviews to validate themes and identify divergence across regions and end-user types. Segmentation logic was applied iteratively to ensure that offerings, components, processing automation levels, preparation methods, applications, and end users were coherently aligned to observed purchasing behavior and clinical workflows. Where appropriate, scenario analysis was used to stress-test procurement and operational responses to tariff shifts and supply disruptions without attempting to estimate market sizes or forecast quantitative outcomes.

A decisive synthesis of strategic priorities and operational adjustments that unify safety, resilience, and integration as the central imperatives for blood preparation stakeholders

The findings converge on a clear imperative: institutions and suppliers must move from transactional interactions to integrated value partnerships that combine resilient sourcing, automation, and data-enabled quality systems. Providers should view investments in processing automation, pathogen mitigation, and software governance not merely as capital projects but as strategic enablers of clinical consistency and supply resilience. Suppliers who offer modular, service-rich, and interoperable solutions will be best positioned to meet the nuanced demands of diverse end users from ambulatory surgical centers to large hospital networks.

At the same time, procurement teams must adopt a more dynamic risk posture that accounts for tariff volatility and regional manufacturing shifts. By aligning clinical validation programs with procurement cycles and engaging in active supplier qualification, organizations can shorten time-to-adoption for high-value technologies while safeguarding continuity of supply. The conclusions here are intended to guide pragmatic decisions that improve patient safety, operational reliability, and cost transparency across the blood preparation lifecycle.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Blood Preparation Market, by Offerings

  • 8.1. Disposables & Consumables
    • 8.1.1. Apheresis Kits
    • 8.1.2. Blood Bag Systems
    • 8.1.3. Leukocyte Reduction Filters
    • 8.1.4. Transfer Sets
    • 8.1.5. Tubing & Needles
  • 8.2. Equipment
    • 8.2.1. Collection Devices
      • 8.2.1.1. Apheresis Machines
      • 8.2.1.2. Blood Collection Mixers
    • 8.2.2. Irradiators
    • 8.2.3. Pathogen Reduction Systems
    • 8.2.4. Processing Equipment
      • 8.2.4.1. Automated Component Extractors
      • 8.2.4.2. Centrifuges
    • 8.2.5. Storage Equipment
      • 8.2.5.1. Blood Bank Refrigerators
      • 8.2.5.2. Cryogenic Freezers
      • 8.2.5.3. Plasma Freezers
      • 8.2.5.4. Platelet Incubators & Agitators
  • 8.3. Software
    • 8.3.1. Blood Establishment
    • 8.3.2. Temperature Monitoring

9. Blood Preparation Market, by Component

  • 9.1. Plasma
  • 9.2. Platelets
  • 9.3. Red Blood Cells
  • 9.4. Whole Blood

10. Blood Preparation Market, by Processing Automation

  • 10.1. Fully Automated
  • 10.2. Manual
  • 10.3. Semi-Automated

11. Blood Preparation Market, by Preparation Method

  • 11.1. Apheresis Processing
  • 11.2. Extraction Workflow
  • 11.3. Freezing & Cryopreservation
  • 11.4. Irradiation
  • 11.5. Leukoreduction
  • 11.6. Pathogen Inactivation
  • 11.7. Washing & Volume Adjustment
  • 11.8. Whole Blood Processing

12. Blood Preparation Market, by Application

  • 12.1. Plasma-Derived Therapies
    • 12.1.1. Autoimmune & Neurologic Disorders
    • 12.1.2. Liver Disease & Critical Care
    • 12.1.3. Primary Immunodeficiency
  • 12.2. Research & Biomanufacturing
  • 12.3. Transfusion Support
    • 12.3.1. Anemia Management
    • 12.3.2. Cardiovascular & Transplant
    • 12.3.3. Hematological Disorders
    • 12.3.4. Obstetrics & Gynecology
    • 12.3.5. Oncology Treatments

13. Blood Preparation Market, by End User

  • 13.1. Ambulatory Surgical Centers
  • 13.2. Blood Banks
  • 13.3. Clinics
  • 13.4. Hospitals

14. Blood Preparation Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Blood Preparation Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Blood Preparation Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Blood Preparation Market

18. China Blood Preparation Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Abbott Laboratories
  • 19.6. AdvaCare Pharma
  • 19.7. AstraZeneca PLC
  • 19.8. B. Braun Melsungen AG
  • 19.9. Baxter International Inc.
  • 19.10. Bayer AG
  • 19.11. Becton, Dickinson, and Company
  • 19.12. Cardinal Health
  • 19.13. CSL Limited
  • 19.14. Daiichi Sankyo
  • 19.15. Delcon SRL
  • 19.16. Exelint International, Co.
  • 19.17. Fresenius Kabi AG
  • 19.18. GlaxoSmithKline PLC
  • 19.19. Greiner Bio-One International GmbH
  • 19.20. Grifols, S.A.
  • 19.21. GVS S.p.A.
  • 19.22. Immucor, Inc.
  • 19.23. Kedrion Holding S.p.A.
  • 19.24. Labotronics Scientific LTD.
  • 19.25. Labtron Equipment Ltd
  • 19.26. LFB SA
  • 19.27. Macopharma S.A.S.
  • 19.28. Medline Industries, Inc.
  • 19.29. Medtronic PLC
  • 19.30. Mitra Industries Private Limited
  • 19.31. Nipro Corporation
  • 19.32. Octapharma AG
  • 19.33. Ortho Clinical Diagnostics Inc.
  • 19.34. Pfizer Inc.
  • 19.35. QIAGEN N.V
  • 19.36. Sanquin
  • 19.37. SARSTEDT AG & Co. KG
  • 19.38. Shanghai Kohope Medical Devices Co., Ltd.
  • 19.39. Terumo Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BLOOD PREPARATION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BLOOD PREPARATION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BLOOD PREPARATION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BAG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOCYTE REDUCTION FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFER SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TUBING & NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS MACHINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD COLLECTION MIXERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN REDUCTION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOMATED COMPONENT EXTRACTORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CENTRIFUGES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANK REFRIGERATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CRYOGENIC FREEZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA FREEZERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELET INCUBATORS & AGITATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD ESTABLISHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TEMPERATURE MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLATELETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RED BLOOD CELLS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FULLY AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BLOOD PREPARATION MARKET SIZE, BY MANUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BLOOD PREPARATION MARKET SIZE, BY SEMI-AUTOMATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APHERESIS PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BLOOD PREPARATION MARKET SIZE, BY EXTRACTION WORKFLOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL BLOOD PREPARATION MARKET SIZE, BY FREEZING & CRYOPRESERVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL BLOOD PREPARATION MARKET SIZE, BY IRRADIATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LEUKOREDUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PATHOGEN INACTIVATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WASHING & VOLUME ADJUSTMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL BLOOD PREPARATION MARKET SIZE, BY WHOLE BLOOD PROCESSING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AUTOIMMUNE & NEUROLOGIC DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL BLOOD PREPARATION MARKET SIZE, BY LIVER DISEASE & CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL BLOOD PREPARATION MARKET SIZE, BY PRIMARY IMMUNODEFICIENCY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL BLOOD PREPARATION MARKET SIZE, BY RESEARCH & BIOMANUFACTURING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ANEMIA MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CARDIOVASCULAR & TRANSPLANT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HEMATOLOGICAL DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL BLOOD PREPARATION MARKET SIZE, BY OBSTETRICS & GYNECOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL BLOOD PREPARATION MARKET SIZE, BY ONCOLOGY TREATMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL BLOOD PREPARATION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL BLOOD PREPARATION MARKET SIZE, BY BLOOD BANKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL BLOOD PREPARATION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL BLOOD PREPARATION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL BLOOD PREPARATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 177. AMERICAS BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 178. AMERICAS BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 179. AMERICAS BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 180. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 182. AMERICAS BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 183. AMERICAS BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 184. AMERICAS BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 186. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 187. AMERICAS BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 188. AMERICAS BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 189. AMERICAS BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 190. AMERICAS BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 206. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 208. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 209. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 210. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 231. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 232. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 233. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 234. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 235. EUROPE, MIDDLE EAST & AFRICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. EUROPE BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPE BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPE BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPE BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPE BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPE BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPE BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPE BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPE BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPE BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPE BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPE BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPE BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPE BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPE BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 265. MIDDLE EAST BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. AFRICA BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. AFRICA BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 268. AFRICA BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 269. AFRICA BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 270. AFRICA BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 271. AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 272. AFRICA BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 273. AFRICA BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 274. AFRICA BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 275. AFRICA BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 276. AFRICA BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 277. AFRICA BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 278. AFRICA BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 279. AFRICA BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 280. AFRICA BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 281. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 282. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 283. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 284. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 285. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 286. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 287. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 288. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 289. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 290. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 291. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 292. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 293. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 294. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 295. ASIA-PACIFIC BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. GLOBAL BLOOD PREPARATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 297. ASEAN BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 298. ASEAN BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 299. ASEAN BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 300. ASEAN BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 301. ASEAN BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 302. ASEAN BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 303. ASEAN BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 304. ASEAN BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. ASEAN BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 306. ASEAN BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 307. ASEAN BLOOD PREPARATION MARKET SIZE, BY PREPARATION METHOD, 2018-2032 (USD MILLION)
  • TABLE 308. ASEAN BLOOD PREPARATION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 309. ASEAN BLOOD PREPARATION MARKET SIZE, BY PLASMA-DERIVED THERAPIES, 2018-2032 (USD MILLION)
  • TABLE 310. ASEAN BLOOD PREPARATION MARKET SIZE, BY TRANSFUSION SUPPORT, 2018-2032 (USD MILLION)
  • TABLE 311. ASEAN BLOOD PREPARATION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 312. GCC BLOOD PREPARATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 313. GCC BLOOD PREPARATION MARKET SIZE, BY OFFERINGS, 2018-2032 (USD MILLION)
  • TABLE 314. GCC BLOOD PREPARATION MARKET SIZE, BY DISPOSABLES & CONSUMABLES, 2018-2032 (USD MILLION)
  • TABLE 315. GCC BLOOD PREPARATION MARKET SIZE, BY EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 316. GCC BLOOD PREPARATION MARKET SIZE, BY COLLECTION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 317. GCC BLOOD PREPARATION MARKET SIZE, BY PROCESSING EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 318. GCC BLOOD PREPARATION MARKET SIZE, BY STORAGE EQUIPMENT, 2018-2032 (USD MILLION)
  • TABLE 319. GCC BLOOD PREPARATION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 320. GCC BLOOD PREPARATION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 321. GCC BLOOD PREPARATION MARKET SIZE, BY PROCESSING AUTOMATION, 2018-2032 (USD MILLION)
  • TABLE 322. GCC BLOOD PREPARATION MARKET SIZE, BY PREPARA